ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 055,60
-0,04%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Reneo Pharmaceuticals Inc (RPHM)

  7. Reneo Pharmaceuticals Inc (RPHM) Actualités

RPHM

Reneo Pharmaceuticals (RPHM)

Reneo Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RPHM
DateHeureSourceTitreSymboleSociété
13/05/202415h38Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RPHMReneo Pharmaceuticals Inc
13/05/202415h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
13/05/202413h35GlobeNewswire Inc.Reneo Pharmaceuticals and OnKure Announce Proposed MergerNASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202422h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202413h35GlobeNewswire Inc.Reneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
28/03/202412h35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business UpdateNASDAQ:RPHMReneo Pharmaceuticals Inc
25/03/202412h00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:RPHMReneo Pharmaceuticals Inc
05/02/202422h01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RPHMReneo Pharmaceuticals Inc
14/12/202315h05GlobeNewswire Inc.Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
22/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202323h08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202322h58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202313h35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
02/11/202312h50GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:RPHMReneo Pharmaceuticals Inc
25/10/202313h50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific MeetingsNASDAQ:RPHMReneo Pharmaceuticals Inc
09/10/202313h50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
06/10/202314h30GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro SummitNASDAQ:RPHMReneo Pharmaceuticals Inc
29/08/202323h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
28/08/202323h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
10/08/202313h35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
30/06/202314h25GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics ForumNASDAQ:RPHMReneo Pharmaceuticals Inc
26/06/202314h25GlobeNewswire Inc.Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® IndicesNASDAQ:RPHMReneo Pharmaceuticals Inc
24/06/202301h12Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:RPHMReneo Pharmaceuticals Inc
15/06/202318h44GlobeNewswire Inc.Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023NASDAQ:RPHMReneo Pharmaceuticals Inc
14/06/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RPHMReneo Pharmaceuticals Inc
09/06/202300h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RPHMReneo Pharmaceuticals Inc
07/06/202322h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RPHMReneo Pharmaceuticals Inc
05/06/202322h08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RPHMReneo Pharmaceuticals Inc
31/05/202316h38GlobeNewswire Inc.Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare ConferenceNASDAQ:RPHMReneo Pharmaceuticals Inc
31/05/202314h00GlobeNewswire Inc.Reneo Pharmaceuticals to Participate at the Jefferies Healthcare ConferenceNASDAQ:RPHMReneo Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RPHM

Dernières Valeurs Consultées

LSE
JEO
European Opportunities
TSXV
LOU
Lucero Energy
COIN
COFEUR
BIT
GAS2S
SG ETC Daily Short-2X Na...
KUCN
QSPETH
Quantstamp
NYSE
KCGI.WS
Kensington Capital Acqui...
USOTC
THDRF
Thai NVDR (PK)
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés